Understanding Antianxiety and Antipsychotic Medications — Chapter 19 Summary from Clinical Psychopharmacology for Therapists
Understanding Antianxiety and Antipsychotic Medications — Chapter 19 Summary from Clinical Psychopharmacology for Therapists Medications for anxiety and psychotic disorders play a vital role in managing complex mental health conditions. Chapter 19 of Clinical Psychopharmacology for Therapists focuses on the pharmacological strategies used to treat anxiety, schizophrenia, bipolar disorder, and related conditions. This chapter explores the mechanisms, uses, and risks of common antianxiety and antipsychotic drugs while unpacking the underlying neurochemical theories that inform their use—particularly the roles of GABA and dopamine . 🎥 Watch the video summary below to gain a clear and concise understanding of this chapter’s key points: Antianxiety Medications and the GABA System The chapter begins with an exploration of the primary classes of antianxiety medications : benzodiazepines, beta-blockers, antihistamines, and buspirone . Of these, benzodiazepines are most frequentl...